Controversies surrounding classification of personality disorder

Psychiatry Investigation

Volumn 7, Issue 1, 2010, Pages 1-8

  Kim, Youl Ri ^b   Tyrer, Peter ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b NONE

Author keywords

Classification; Personality disorder; Severity; Treatment

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; HALOPERIDOL; MONOAMINE OXIDASE INHIBITOR; MOOD STABILIZER; OMEGA 3 FATTY ACID; SEROTONIN UPTAKE INHIBITOR;

AFFECT; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITION; COGNITIVE THERAPY; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE CLASSIFICATION; DISEASE SEVERITY; EMOTION; HELP SEEKING BEHAVIOR; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MENTAL DISEASE; MOOD; PERSONALITY DISORDER; PRACTICE GUIDELINE; PSYCHOTHERAPY; REVIEW; RISK FACTOR;

EID: 77950851171     PISSN: 17383684     EISSN: None     Source Type: Journal    
DOI: 10.4306/pi.2010.7.1.1     Document Type: Review

References (76)

1. Grant BF, Hasin DS, Stinson FS, Dawson DA, Chou SR, Ruan WJ, et al. Prevalence, correlates, and disability of personality disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry 2004; 65: 948-958.
2. Moran P, Jenkins R, Tylee A, Blizard R, Mann A. The prevalence of personality disorder among UK primary care attenders. Acta PsychiatrScand 2000; 102: 52-57. (Pubitemid 30409056)
3. Tyrer P, Casey P, Gall J. Relationship between neurosis and personality disorder. Br J Psychiatry 1983; 142: 404-408. (Pubitemid 13164256)
4. Fazel S, Danesh J. Serious mental disorder in 23000 prisoners: a systematic review of 62 surveys. Lancet 2002; 359: 545-550. (Pubitemid 34178434)
5. Ranger M, Methuen C, Rutter D. Prevalence of personality disorder in the case road of an inner city assertive outreach team. Psychiatr Bull 2004; 28: 441-443. (Pubitemid 39646573)
6. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (4th edition). Washington, DC: American Psychiatric Association; 1994.
7. World Health Organization. ICD 10 Classification of mental and behavioral disorders: Clinical descriptions and diagnostic guidelines. Geneva: World Health Organization; 1992.
8. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (3rd edition). Washington, DC: American Psychiatric Association; 1980.
9. Tyrer P, Seivewright N, Ferguson B, Tyrer J. The general neurotic syndrome: a coaxial diagnosis of anxiety, depression and personality disorder. Acta Psychiatr Scand 1992; 85: 201-206.
10. Crawford TN, Cohen P, First MB, Skodol AE, Johnson JG, Kasen S. Comorbid Axis I and Axis II disorders in early adolescence: outcomes 20 years later. Arch Gen Psychiatry 2008; 65: 641-648. (Pubitemid 351787235)
11. Newton-Howes G, Tyrer P, Johnson T. Personality disorder and the outcome of depression: meta-analysis of published studies. Br J Psychiatry 2006; 188: 13-20. (Pubitemid 43021921)
12. Beard JR, Heathcote K, Brooks R, Earnest A, Kelly B. Predictors of mental disorders and their outcome in a community based cohort. Soc Psychiatry Psychiatr Epidemiol 2007; 42: 623-630. (Pubitemid 47190037)
13. Newton-Howes G, Tyrer P, Weaver T. Social functioning of patients with personality disorder in secondary care. Psychiatr Serv 2008; 59: 1033-1037.
14. Tyrer P, Mulder R, Crawford M, Newton-Howes G, Simonsen E, Ndetei D, et al. Personality disorder: a new global perspective. World Psychiatry 2010; 9: 56-60.
15. Tyrer P, Coombs N, Ibrahimi F, Mathilakath A, Bajaj P, Ranger M, et al. Critical developments in the assessment of personality disorder. Br J Psychiatry Suppl 2007; 49: S51-S59. (Pubitemid 46706943)
16. Livesley WJ, Schroeder ML, Jackson DN, Jang KL. Categorical distinctions in the study of personality disorder: implications for classification. J Abnorm Psychol 1994; 103: 6-17.
17. Widiger TA, Simonsen E, Krueger R, Livesley WJ, Verheul R. Personality disorder research agenda for the DSM-V. J Pers Disord 2005; 19: 315-338.
18. Persly AS, Walton HJ. Dimensions of abnormal personality. Br J Psychiatry 1973; 122: 269-276.
19. Tyrer P, Alexander MS, Cicchetti D, Cohen MS, Remington M. Reliability of a schedule for rating personality disorders. Br J Psychiatry 1979; 135: 168-174.
20. Clark LA, Livesley WJ, Schroeder ML, Irish SL. Convergence of two systems for assessing specific traits of personality disorder. Psycholl Assess 1996; 8: 294-303.
21. Mulder RT, Joyce PR. Temperament and the structure of personality disorder symptoms. Psychol Med 1997; 27: 99-106.
22. Tyrer P, Alexander J. Classification of personality disorder. Br J Psychiatry 1979; 135: 163-167.
23. Eysenck HJ, Eysenck MW. Personality and individual differences: a natural science approach. New York: Plenum Press; 1985.
24. McCrae RR, Costa PT Jr. Validation of the five-factor model of personality across instruments and observers. J Pers Sec Psycholo 1987; 52: 81-90.
25. Livesley WJ, Jang KL, Vernon PA. Phenotypic and genetic structure of traits delineating personality disorder. Arch Gen Psychiatry 1998; 55: 941-948.
26. Cloninger CR, Przybeck TR, Svrakic DM. The tridimensional personality questionnaire: U. S. normative data. Psychol Rep 1991; 69 (3 Pt 1) : 1047-1057.
27. Clark LA, Livesley WJ, Morey L. Personality disorder assessment: the challenge of construct validity. J Pers Disord 1997; 11: 205-231.
28. Mann AH, Jenkins R, Cutting JC, Cowen PJ. The development and use of standardized assessment of abnormal personality. Psychol Med 1981; 11: 839-847.
29. Pfohl B, Blum N, Zimmerman M. Structured interview for DSM-IV personality: SIDP-IV. Iowa City: University of Iowa, Department of psychiatry; 1995.
30. First MB, Spitzer RL, Gibbon M, Williams JBW. The Structured Clinical Interview for DSM-UJ-R Personality Disorders (SCID-H.) : Part 1: Description. J Pers Disord 1995; 9: 83-91.
31. Tyrer P, Alexander J, Ferguson B. Personality Assessment Schedule. In: Tyrer P, ed. Personality disorders: diagnosis, management and course (2nd ed). London: Arnold, London; 2000.
32. Moran P, Walsh E, Tyrer P, Burns T, Creed F, Fahy T. Impact of comorbid personality disorder on violence in psychosis: report from the UK700 trial. Br J Psychiatry 2003; 182: 129-134.
33. Schroeder ML, Wormsworth JA, Livesley WJ. Dimensions of personality disorder and their relationships to die big five dimensions of personality. Psychol Assess 1992; 4: 47-53.
34. Zanarini MC, Frankenburg FR, Hennen J, Silk KR. The longitudinal course of borderline psychopathology: 6-year prospective follow-up of the phenomenology of borderline personality disorder. Am J Psychiatry 2003; 160: 274-283.
35. Paris J. Implications of long-term outcome research for the management of patients with borderline personality disorder. Harv Rev Psychiatry 2002; 10: 315-323. (Pubitemid 36055689)
36. Seivewright H, Tyrer P, Johnson T. Change in personality status in neurotic disorders. Lancet 2002; 359: 2253-2254.
37. Shea MT, Stout R, Gunderson J, Morey LC, Grilo CM, McGlashan T, et al. Short-term diagnostic stability of schizotypal, borderline, avoidant, and obsessive-compulsive personality disorders. Am J Psychiatry 2002; 159: 2036-2041.
38. Shea MT, Yen S. Stability as a distinction between Axis I and Axis II disorders. J Pers Disord 2003; 17:373-386.
39. Skodol AE, Oldham JM, Bender DS, Dyck IR, Stout RL, Morey LC, et al. Dimensional representations of DSM-IV personality disorders: relationships to functional impairment. Am J Psychiatry 2005; 162: 1919-1925.
40. Grilo CM, Sanislow CA, Gunderson JG, Pagano ME, Yen S, Zanarini MC, et al. Two-year stability and change of schizotypal, borderline, avoidant, and obsessive-compulsive personality disorders. J Consult Clin Psychol 2004; 72: 767-775.
41. Tyrer P, Morgan J, Cicchetti D. The Dependent Personality Questionnaire (DPQ) : a screening instrument for dependent personality. Intl J Soc Psychiatry 2004; 50: 10-17.
42. Reich J, Nduaguba M, Yates W Age and sex distribution of DSM-III personality cluster traits in a community population. Compr Psychiatry 1988; 29: 298-303.
43. Links PS, Heslegrave R, van Reekum R. Prospective follow-up study of borderline personality disorder: prognosis, prediction of outcome, and Axis II comorbidity. Can J Psychiatry 1998; 43: 265-270.
44. Seivewright H, Tyrer P, Johnson T. Persistent social dysfunction in anxious and depressed patients with personality disorder. Acta Psychiatr Scand 2004; 109: 104-109.
45. Paris J, Zweig-Frank H. A 27-year follow-up of patients with borderline personality disorder. Compr Psychiatry 2001; 42: 482-487.
46. Tyrer P, Johnson T. Establishing the severity of personality disorder. Am J Psychiatry 1996; 153: 1593-1597.
47. Oldham JM, Skodol AE, Kellman HD, Hyler SE, Rosnick L, Davies M. Diagnosis of DSM-UJ-R personality disorders by two structured interviews: patterns of comorbidity. Am J Psychiatry 1992; 149: 213-220.
48. Dolan B, Evans C, Norton K. Multiple axis-II diagnoses of personality disorder. Br J Psychiatry 1995; 166: 107-112.
49. Tyrer P, Mitchard S, Methuen C, Ranger M. Treatment rejecting and treatment seeking personality disorders: Type R and Type S. J Pers Disord 2003; 17: 263-268. (Pubitemid 36741565)
50. Tyrer P. Nidotherapy: a new approach to the treatment of personality disorder. Acta Psychiatr Scand 2002; 105: 469-471; discussion 471-472.
51. Tyrer P, Bajaj P. Nodotherapy: making the environment to the therapeutic work. Advances in Psychiatric Treatment 2005; 11: 232-238.
52. Tyrer P, Sensky T, Mitchard S. Principles of nidotherapy in the treatment of persistent mental and personality disorders. Psychother Psychosom 2003; 72: 350-356.
53. Tyrer P. Personality disorder. In: Murray RM, Kendler KS, McGuffin P, Wessely S, Castle DJ, editors. Essential Psychiatry. Cambridge: Cambridge University Press; 2008. p. 135-146.
54. Bateman A, Fonagy P. Treatment of borderline personality disorder with psychoanalytically oriented partial hospitalization: an 18-month follow-up. Am J Psychiatry 2001; 158: 36-42.
55. Bateman A, Fonagy P. Health service utilization costs for borderline personality disorder patients treated with psychoanalytically oriented partial hospitalization versus general psychiatric care. Am J Psychiatry 2003; 160: 169-171.
56. GerberAJ, Fonagy P, Bateman A, Higgitt A. Structural and symptomatic change in psychoanalysis and psychodynamic psychotherapy of young adults: a quantitative study of process and outcome. Journal of the American Psychoanalytic Association 2004; 52: 1235-1236.
57. Bateman A, Fonagy P. Effectiveness of partial hospitalization in the treatment of borderline personality disorder: a randomized controlled trial. Am J Psychiatry 1991; 156: 1563-1569
58. Linehan MM, Armstrong HE, Suarez A, Allmon D, Heard HL. Cognitive-behavioral treatment of chronically parasuicidal borderline patients. Arch Gen Psychiatry 1991; 48: 1060-1064.
59. Verheul R, Van Den Bosch LM, Koeter MW, De Ridder MA, Stijnen T, Van Den Brink W. Dialectical behaviour therapy for women with borderline personality disorder: 12-month, randomised clinical trial in The Netherlands. Br J Psychiatry 2003; 182: 135-140.
60. Evans K, Tyrer P, Catalan J, Schmidt U, Davidson K, Dent J, et al. Manual-assisted cognitive-behaviour therapy (MACT) : a randomized controlled trial of a brief intervention with bibliotherapy in the treatment of recurrent deliberate self-harm. Psychol Med 1999; 29: 19-25.
61. Tyrer P, Thompson S, Schmidt U, Jones V, Knapp M, Davidson K, et al. Randomized controlled trial of brief cognitive behaviour therapy versus treatment as usual in recurrent deliberate self-harm: the POP-MACT study. Psychol Med 2003; 33: 969-976. (Pubitemid 37009815)
62. Tyrer P, Tom B, Byford S, Schmidt U, Jones V, Davidson K, et al. Differential effects of manual assisted cognitive behavior therapy in the treatment of recurrent deliberate self-harm and personality disturbance: the POPMACT study. J Pers Disord 2004; 18: 102-116.
63. Guthrie E, Kapur N, Mackway-Jones K, Chew-Graham C, Moorey J, Mendel E, et al. Randomised controlled trial of brief psychological intervention after deliberate self poisoning. BMJ 2001; 323: 135-138.
64. Ryle A. The contribution of cognitive analytic therapy to the treatment of borderline personality disorder. J Pers Disord 2004; 18: 3-35.
65. Chiesa M, Fonagy P. Cassel personality disorder study. Methodology and treatment effects. Br J Psychiatry 2000; 176: 485-491.
66. Clarkin JF, Yeomans F, Kemberg OF. Psychotherapy for borderline personality. New York: Wiley; 1999.
67. Clarkin JF, Levy KN, Lenzenweger MF, Kemberg OF. The Personality Disorders Institute/Borderline Personality Disorder Research Foundation randomized control trial for borderline personality disorder: rationale, methods, and patient characteristics. J Pers Disord 2004; 18: 52-72.
68. Ranger M, Tyrer P, Miloseska K, Fourie H, Khaleel I, North B, et al. Cost-effectiveness of nidotherapy for comorbid personality disorder and severe mental illness: randomized controlled trial. Epidemiol Psichiatr Soc 2009; 18: 128-136.
69. Cornelius JR, Soloff PH, Perel JM, Ulrich RF. Continuation pharmacotherapy of borderline personality disorder with haloperidol and phenelzine. Am J Psychiatry 1993; 150: 1843-1848.
70. Soloff PH, George A, Nathan RS, Schulz PM, Ulrich RF, Perel JM. Progress in pharmacotherapy of borderline disorders disorders. A double-blind study of amitryptiline, haloperidol, and placebo. Arch Gen Psychiatry 1986; 43: 691-697.
71. Coccaro EF, Kavoussi RJ. Fluoxetine and impulsive aggressive behavior in personality-disordered subjects. Arch Gen Psychiatry 1997; 54: 1081-1088.
72. Salzman C, Wolfson AN, Schatzberg A, Looper J, Henke R, Albanese M, et al. Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder. J Clin Psychopharmacol 1995; 15: 23-29.
73. Verkes RJ, Van der Mast RC, Hengeveld MW, Tuyl JP, Zwinderman AH, Van Kempen GM. Reduction by paroxetine of suicidal behavior in patients with repeated suicide attempts but not major depression. Am J Psychiatry 1998; 155: 543-547.
74. American Psychiatric Association Practice Guidelines. Practice guideline for the treatment of patients with borderline personality disorder. American Psychiatric Association. Am J Psychiatry 2001; 158 (10 Suppl) : 1-52.
75. Newton-Howes G, Tyrer P. Pharmacotherapy for personality disorders. Expert Opin Phannacother 2003; 4: 1643-1649.
76. Tyrer P, Bateman A. Drug treatment for personality disorders. Advances in Psychiatric Treatment 2004; 10: 389-398.